You are here:

Category: 4.9 Drugs used in Parkinsonism and related disorders

Name SMC ID No Manufacturer Status Sub. Type
 
co-careldopa-levodopa (Duodopa) 316/06 AbbVie Ltd Restricted Resubmission
co-careldopa (Duodopa) 316/06 AbbVie Ltd Not Recommended Resubmission
Clostridium botulinum type A neurotoxin (Botox®) 80/03 Allergan Ltd Not Recommended Resubmission
Clostridium botulinum toxin type A neurotoxin (Botox®) 80/03 Allergan Ltd Not Recommended Full submission
clostridium botulinum type A neurotoxin (Botox) 80/03 Allergan Ltd Accepted Resubmission
botulinum toxin (Vistabel) 680/11 Allergan Ltd Not Recommended Non submission
botulinum toxin type a (Botox) 692/11 Allergan Ltd Not Recommended Full submission
botulinum toxin type a (Botox) 692/11 Allergan Ltd Not Recommended Resubmission
botulinum toxin A (Botox) 692/11 Allergan Ltd Restricted Resubmission
pramipexole (Mirapexin) 247/06 Boehringer Ingelheim Ltd Accepted Full submission
pramipexole (Mirapexin) 580/09 Boehringer Ingelheim Ltd Accepted Abbreviated Submission
botulinum toxin Type A (Azzalure) 679/11 Galderma (UK) Ltd Not Recommended Non submission
ropinirole tablets (Adartrel) 165/05 GlaxoSmithKline UK Ltd Restricted Resubmission
ropinirole prolonged release (Requip XL) 491/08 GlaxoSmithKline UK Ltd Accepted Abbreviated Submission
clostridium botulinum toxin A (Dysport) 353/07 Ipsen Ltd Restricted Resubmission
Rasagiline 1mg tablet (Azilect®) 255/06 Lundbeck Ltd Not Recommended Full submission
rasagiline 1mg (Azilect) 255/06 Lundbeck Ltd Not Recommended Resubmission
Rasagiline 1mg tablet (Azilect®) 243/06 Lundbeck Ltd Not Recommended Full submission
rasagiline 1mg tablet monotherapy (Azilect) 243/06 Lundbeck Ltd Not Recommended Resubmission
botulinum toxin type a (Bocouture) 695/11 Merz Pharma UK Ltd Not Recommended Non submission
botulinum toxin type A (Xeomin®) 731/11 Merz Pharma UK Ltd Accepted Abbreviated Submission
Levodopa, carbidopa and entacapone (Stalevo) 85/03 Orion Pharma (UK) Ltd Accepted Abbreviated Submission
rotigotine 2mg/24 hours, 4mg/24 hours, 6mg/24 hours, 8mg/24 hours transdermal patch (Neupro) 289/06 Schwarz Pharma Ltd Not Recommended Full submission
rotigotine 2mg/24 hours, 4mg/24 hours, 6mg/24 hours, 8mg/24 hours transdermal patch (Neupro) 289/06 Schwarz Pharma Ltd Accepted Resubmission
rotigotine (Neupro) 392/07 Schwarz Pharma Ltd Restricted Full submission
co-careldopa intestinal gel, 20mg/5mg levodopa/cabidopa per ml for continuous intestinal infusion (Duodopa) 316/06 Solvay Healthcare Ltd Not Recommended Full submission
rotigotine (Neupro) 548/09 UCB Pharma Ltd Accepted Full submission

Back